ImmunityBio, Inc.

IBRX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001326110

SEC filings (opens in a new tab)

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 2 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding ImmunityBio, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of IBRX: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	182	4	202	+24
Shares	68.7M	156.1K	82.7M	+14.1M (+20.6%)
Value	$255.6M	$391.1K	$211.8M	−$43.4M (−17.0%)

4 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (44)

Institutions that held ImmunityBio, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to IBRX in Q4 2024
Institution	Shares	Value	% of portfolio
Cormorant Asset Management, LP	3,000,000	$7.68M	0.42%
Tang Capital Management LLC	2,814,192	$7.20M	0.48%
Perceptive Advisors LLC	1,221,734	$3.13M	0.09%
Altium Capital Management LP	1,060,000	$2.71M	0.85%
Ghisallo Capital Management LLC	500,000	$1.28M	0.07%
Group One Trading, L.P.	498,429	$1.28M	0.04%
Marshall Wace, LLP	240,311	$615.2K	0.00%
Mirae Asset Securities (USA) Inc.	140,880	$360.7K	0.02%
Brevan Howard Capital Management LP	99,757	$255.4K	0.01%
Engineers Gate Manager LP	92,377	$236.5K	0.00%
Raymond James Financial Inc	67,354	$172.4K	0.00%
Capula Management Ltd	60,101	$153.9K	0.00%
LMR Partners LLP	47,402	$121.3K	0.00%
Police & Firemen's Retirement System of New Jersey	36,311	$93.0K	0.00%
BNP Paribas Arbitrage, SA	34,988	$89.6K	0.00%
Fox Run Management, L.L.C.	33,504	$85.8K	0.02%
Wexford Capital LP	33,113	$84.8K	0.02%
Two Sigma Investments, LP	28,317	$72.5K	0.00%
Dark Forest Capital Management LP	25,144	$64.4K	0.01%
SBI Securities Co., Ltd.	22,677	$58.1K	0.00%
KLP Kapitalforvaltning AS	22,100	$56.6K	0.00%
Financial Advisors Network, Inc.	20,000	$51.2K	0.01%
Mutual Advisors, LLC	16,200	$49.2K	0.00%
Creative Planning	18,716	$47.9K	0.00%
Maia Wealth LLC	14,396	$45.1K	0.01%
HSBC Holdings PLC	16,840	$43.9K	0.00%
Crestwood Advisors Group LLC	16,200	$41.5K	0.00%
Ameriprise Financial Inc	15,014	$38.4K	0.00%
Schechter Investment Advisors, LLC	15,000	$38.4K	0.00%
Warren Averett Asset Management, LLC	14,762	$37.8K	0.00%
GF Fund Management Co. Ltd.	14,632	$37.5K	0.00%
CIBC World Markets Corp	13,546	$34.7K	0.00%
CIBC World Markets Inc.	12,700	$33.0K	0.00%
Stephens Inc	10,090	$25.8K	0.00%
Caitong International Asset Management Co., Ltd	9,946	$25.5K	0.02%
Aster Capital Management (DIFC) Ltd	2,004	$5.13K	0.00%
Golden State Wealth Management, LLC	700	$1.79K	0.00%
MAI Capital Management	348	$891	0.00%
Van Hulzen Asset Management, LLC	200	$512	0.00%
IFP Advisors, Inc	85	$218	0.00%
CoreCap Advisors, LLC	70	$179	0.00%
Marshall & Sterling Wealth Advisors Inc.	50	$128	0.00%
Global Financial Private Client, LLC	13	$33	0.00%
Parkworth Wealth Management, Inc.	3	$8	0.00%

Sold out (20)

Institutions that held ImmunityBio, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of IBRX in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
D. E. Shaw & Co., Inc.	520,053	$1.93M
HarbourVest Partners LLC	335,709	$1.25M
ExodusPoint Capital Management, LP	135,029	$502.0K
Squarepoint Ops LLC	109,485	$407.3K
Sherbrooke Park Advisers LLC	75,078	$279.3K
Advantage Alpha Capital Partners LP	69,207	$257.4K
Balyasny Asset Management LLC	65,811	$244.8K
Caption Management, LLC	26,032	$96.8K
Catalyst Funds Management Pty Ltd	20,600	$76.6K
Integrated Wealth Concepts LLC	17,158	$63.8K
Cambridge Investment Research Advisors, Inc.	14,519	$54.0K
Virtu Financial LLC	13,608	$51.0K
Acadian Asset Management LLC	12,432	$46.0K
Captrust Financial Advisors	11,073	$41.2K
Susquehanna Portfolio Strategies, LLC	10,392	$38.7K
Arcadia Investment Management Corp	1,000	$3.71K
Clear Street Markets LLC	897	$3.00K
Headlands Technologies LLC	264	$982
MeadowBrook Investment Advisors LLC	200	$744
Fortitude Family Office, LLC	95	$353

Not filed for Q4 2024 yet (4)

Institutions that held ImmunityBio, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IBRX in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Winning Points Advisors, LLC	89,396	$143.0K
Raymond James & Associates	30,613	$113.9K
Raymond James Financial Services Advisors, Inc.	21,301	$79.2K
Planning Capital Management Corp	14,757	$54.9K